Polaris Partners

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells. It studies cancer-driving pathways and their effect on creating cancer medicines. Delphia Therapeutics is based in Boston, USA.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Boxever Ltd. is a customer intelligence service provider specializing in the travel industry, founded in 2010 and headquartered in Dublin, Ireland, with an additional office in Boston. The company leverages data and artificial intelligence to help travel companies enhance customer relationships by integrating both online and offline customer data. Boxever's platform includes several key solutions: BOXEVER TX, which visualizes the customer journey; TX-CORE, a traveler experience management platform that anticipates customer needs; and TX-NOW, an offer management platform. The company collaborates with major brands, including Emirates and Ryanair, to deliver personalized customer experiences and optimize every interaction. Recognized for its innovative use of AI, Boxever has been acknowledged as a leading player in personalization within the industry.

Boxever Ltd. is a customer intelligence service provider specializing in the travel industry, founded in 2010 and headquartered in Dublin, Ireland, with an additional office in Boston. The company leverages data and artificial intelligence to help travel companies enhance customer relationships by integrating both online and offline customer data. Boxever's platform includes several key solutions: BOXEVER TX, which visualizes the customer journey; TX-CORE, a traveler experience management platform that anticipates customer needs; and TX-NOW, an offer management platform. The company collaborates with major brands, including Emirates and Ryanair, to deliver personalized customer experiences and optimize every interaction. Recognized for its innovative use of AI, Boxever has been acknowledged as a leading player in personalization within the industry.

Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.